Drug:
Reaction: ERYTHEMA
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26896200 |
|||
Bladder disorder, Erythema, |
||||
| 402 | 26896317 |
US |
30 | 1 |
Flushing, Dry skin, Erythema, Skin exfoliation, Paraesthesia, Skin burning sensation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 403 | 26896572 |
US |
1 | |
Erythema, Periorbital irritation, Periorbital inflammation, Multiple allergies, |
||||
DUPILUMAB, |
||||
| 404 | 26896574 |
US |
1 | |
Erythema, |
||||
DUPILUMAB, ITRACONAZOLE, |
||||
| 405 | 26896801 |
US |
79 | 2 |
Dry skin, Sleep disorder, Erythema, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 406 | 26896845 |
US |
2 | |
Eye pruritus, Rash, Erythema, |
||||
BIMATOPROST, |
||||
| 407 | 26896950 |
US |
2 | |
Hospitalisation, Aortic stenosis, Lymphoma, Salivary gland cancer, Lip dry, Weight decreased, Swelling face, Onycholysis, Fungal skin infection, Dry mouth, Insomnia, Aspartate aminotransferase abnormal, Alanine aminotransferase abnormal, Erythema, Hypersensitivity, Alopecia, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, ORAL SEMAGLUTIDE, |
||||
| 408 | 26896955 |
US |
16 | 2 |
Eczema, Erythema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 409 | 26897142 |
GB |
58 | |
Drug reaction with eosinophilia and systemic symptoms, Periorbital oedema, Hepatic function abnormal, Influenza like illness, Drug eruption, Rash maculo-papular, Erythema, Skin exfoliation, Pruritus, |
||||
CENOBAMATE, CENOBAMATE, ZONISAMIDE, |
||||
| 410 | 26897316 |
US |
1 | |
Erythema, Somnolence, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, |
||||
| 411 | 26897332 |
US |
2 | |
Asthenia, Nasopharyngitis, Erythema, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HBR, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, ACETAMINOPHEN, DOXYLAMINE SUCCINATE, |
||||
| 412 | 26924543 |
2 | ||
Erythema, Device difficult to use, Injury associated with device, Skin abrasion, |
||||
TREPROSTINIL, MACITENTAN, SOTATERCEPT-CSRK, TADALAFIL, |
||||
| 413 | 26886650 |
CN |
50 | 1 |
Rash, Erythema, Genital erosion, Tenderness, Tongue ulceration, Pruritus, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 414 | 26886805 |
US |
74 | 1 |
Nasal dryness, Pruritus, Erythema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BRIMONIDINE TARTRATE, ESCITALOPRAM OXALATE, ESCITALOPRAM, LATANOPROST, LISINOPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 415 | 26887071 |
US |
12 | 1 |
Eczema, Therapeutic response shortened, Erythema, Pruritus, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 416 | 26887161 |
TH |
54 | 2 |
Erythema, Chest discomfort, Hypersensitivity, |
||||
AMIVANTAMAB-VMJW, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 417 | 26887293 |
US |
30 | 2 |
Injection site reaction, Erythema, Swelling, Urticaria, |
||||
DUPILUMAB, LANSOPRAZOLE, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 418 | 26887614 |
EU |
1 | 1 |
Erythema multiforme, Urticaria, Erythema, Oedema peripheral, Feeling hot, Irritability, Crying, Leukocytosis, Hyperaesthesia, SARS-CoV-2 test positive, Abnormal faeces, Vaccination complication, C-reactive protein increased, Pyrexia, Rash, |
||||
NIRSEVIMAB, DEXTROSE MONOHYDRATE, DEXTROSE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, ACYCLOVIR, ACYCLOVIR, |
||||
| 419 | 26888131 |
EU |
11 | 1 |
Anaphylactic reaction, Hypotension, Tachycardia, Bronchospasm, Erythema, |
||||
ROCURONIUM BROMIDE, SUGAMMADEX, SUGAMMADEX SODIUM, SEVOFLURANE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PROPOFOL, PROPOFOL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SEVOFLURANE, MORPHINE, |
||||
| 420 | 26888361 |
EU |
56 | 2 |
Vitiligo, Erythema, Skin exfoliation, Onychoclasis, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, |
||||
| 421 | 26888375 |
EU |
55 | 1 |
Psoriatic arthropathy, Palmoplantar pustulosis, Pain, Tenderness, Mood swings, Erythema, Oral infection, Rash, Headache, |
||||
ADALIMUMAB-ADAZ, |
||||
| 422 | 26888546 |
CA |
44 | 1 |
Eye infection, Ocular hyperaemia, Swelling of eyelid, Eye discharge, Skin swelling, Condition aggravated, Erythema, Condition aggravated, Skin exfoliation, Dermatitis atopic, Fear of injection, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 423 | 26888886 |
EU |
42 | 2 |
Anaphylactic reaction, Tremor, Wheezing, Erythema, Tachycardia, Rhinorrhoea, Pruritus, Off label use, Dyspnoea, |
||||
CARBOPLATIN, ACALABRUTINIB, EPINEPHRINE, ADRENALINUM, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 424 | 26888952 |
US |
70 | 2 |
Cellulitis, Pyrexia, Erythema, |
||||
ALGLUCOSIDASE ALFA, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, STERILE WATER FOR INJECTION, FUROSEMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, NYSTATIN TOPICAL POWDER, LORAZEPAM, ALBUTEROL SULFATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, LORATADINE, LORATADINE TABLET, BUPROPION HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, LORATADINE, LORATADINE TABLET, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, OXYGEN, 0XYGEN, ERGOCALCIFEROL, GABAPENTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 425 | 26889057 |
US |
2 | |
Erythema, Pruritus, |
||||
TIRZEPATIDE, |
||||
| 426 | 26889152 |
US |
64 | 2 |
Breast haemorrhage, Lymphadenopathy, Dehydration, Erythema, Pain in extremity, Joint noise, Malaise, |
||||
CAPECITABINE, CAPECITABINE, |
||||
| 427 | 26889312 |
US |
38 | 1 |
Flushing, Erythema, |
||||
ELOSULFASE ALFA, EPINEPHRINE, ADRENALINUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METOPROLOL TARTRATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, LIDOCAINE AND PRILOCAINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE SODIUM SUCCINATE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 428 | 26889315 |
US |
2 | |
Erythema, |
||||
DUPILUMAB, |
||||
| 429 | 26889630 |
BR |
62 | 2 |
Feeling abnormal, Atrioventricular block, Cardiac arrest, Cardiac disorder, Genital swelling, Recurrent cancer, Diabetes mellitus inadequate control, Vision blurred, Cataract, Pneumonia, Fatigue, Pyrexia, Tachycardia, Peripheral swelling, Arrhythmia, Brain neoplasm malignant, Neoplasm malignant, Loss of consciousness, Depression, Renal impairment, Swelling face, Swelling, Alveolar lung disease, Pituitary tumour, Metastases to bone, Syncope, Tumour pain, Angina pectoris, Chest pain, Metastasis, Spinal cord neoplasm, Bone marrow infiltration, Psychotic behaviour, Gallbladder neoplasm, Intestinal obstruction, Syncope, Hepatomegaly, Cardiomegaly, Pancreatic disorder, Gastrointestinal motility disorder, Thyroid neoplasm, Fibromyalgia, Malaise, Muscle atrophy, Weight decreased, Thyroid neoplasm, Weight increased, Nervousness, Pain, Eating disorder, Dehydration, Nail discolouration, Dyspnoea, Asthenia, Lymphatic system neoplasm, Pain in extremity, Neoplasm, Sciatica, Fall, Personality disorder, Dyspepsia, Muscle neoplasm, Gastrointestinal hypomotility, Gait disturbance, Head injury, Sleep disorder, Concomitant disease aggravated, Mood swings, Swollen tongue, Eye swelling, Coordination abnormal, Arthralgia, Lung disorder, Wheezing, Emotional disorder, Depressed mood, Memory impairment, Muscular weakness, Discomfort, Skin discolouration, Cough, Erythema, Decreased appetite, Feeling hot, Vein disorder, Stress, Tension, Apathy, Taste disorder, Dysstasia, Cardiovascular disorder, Dysphonia, Sluggishness, Somnolence, General physical health deterioration, Psychological trauma, Quality of life decreased, Platelet count decreased, Body height increased, Disturbance in attention, Volume blood decreased, Post procedural complication, Adenoma benign, Gastrointestinal neoplasm, Skin discolouration, Rhinorrhoea, Mass, Hormone level abnormal, Tongue discolouration, Blood potassium decreased, Blood sodium decreased, Anger, Renal pain, Salivary hypersecretion, Hot flush, Nausea, Headache, Dizziness, Abdominal distension, Suffocation feeling, Flatulence, Alopecia, Mood altered, Anxiety, Dysgraphia, Back pain, Bone formation decreased, Dysphagia, Regurgitation, Balance disorder, Mental disorder, Asthenia, Gait disturbance, Thyroid disorder, Restlessness, Foot deformity, Hand deformity, Nausea, Injection site mass, Injection site pain, Injection site hypoaesthesia, Incorrect dose administered, Drug ineffective, Wrong technique in product usage process, Needle issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, LANREOTIDE ACETATE, FUROSEMIDE, FUROSEMIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CLONAZEPAM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 430 | 26889714 |
US |
77 | 1 |
Malignant melanoma, Haematological infection, Skin exfoliation, Erythema, Inflammation, Condition aggravated, Joint swelling, Peripheral swelling, Gait disturbance, Feeling cold, Dry mouth, Chills, Chapped lips, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 431 | 26889716 |
US |
53 | 2 |
Dermatitis atopic, Erythema, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 432 | 26889886 |
JP |
61 | 1 |
Contraindicated product administered, Cough, Oropharyngeal discomfort, Dyspnoea, Erythema, |
||||
IOMEPROL INJECTION, |
||||
| 433 | 26889942 |
CA |
51 | 2 |
Acne, Urticaria, Urticaria, Urticaria, Respiratory disorder, Pyrexia, Productive cough, Product administered at inappropriate site, Pneumonia, Peripheral swelling, Off label use, Musculoskeletal pain, Inflammation, Inappropriate schedule of product administration, Hypercholesterolaemia, Cough, Brain fog, Arthralgia, Amnesia, Gait disturbance, Drug effect less than expected, Erythema, Erythema, Fatigue, Feeling hot, Gallbladder disorder, Hair disorder, Headache, Hot flush, Influenza, Musculoskeletal stiffness, Amenorrhoea, Myalgia, Nasal congestion, Nasal discharge discolouration, Pain, Paraesthesia, Pruritus, Pruritus, Pruritus, Pruritus, Pruritus, Asthma, Pruritus, Skin plaque, Skin plaque, Skin plaque, Skin plaque, Skin sensitisation, Stress, Urticaria, Urticaria, Vaginal haemorrhage, Behaviour disorder, Weight increased, Bronchitis, Chills, Chills, Choking, Dyspnoea, |
||||
CYCLOSPORINE, CYCLOSPORINE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, |
||||
| 434 | 26890074 |
US |
35 | 2 |
Injection site pain, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 435 | 26890084 |
CO |
63 | 2 |
Product administration error, Rash, Condition aggravated, Skin hyperpigmentation, Groin pain, Erythema, Ill-defined disorder, Pain in extremity, Peripheral venous disease, Discouragement, Dizziness, Pain, Blood glucose abnormal, Rash macular, Headache, |
||||
INCLISIRAN, INCLISIRAN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 436 | 26890214 |
GB |
76 | |
Cerebrovascular accident, Blister, Erythema, Malaise, |
||||
ALIROCUMAB, |
||||
| 437 | 26890280 |
US |
||
Erythema, Blood pressure increased, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 438 | 26890308 |
US |
86 | 1 |
Off label use, Pain in extremity, Erythema, Rash macular, Arthralgia, |
||||
PIRTOBRUTINIB, |
||||
| 439 | 26890356 |
GB |
||
Dermatitis exfoliative, Erythema, Skin exfoliation, Dry skin, Pruritus, Malaise, Feeling cold, Chills, Body temperature abnormal, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 440 | 26890515 |
EU |
84 | 2 |
Erythema, Acute kidney injury, Diarrhoea, |
||||
ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, |
||||
| 441 | 26890544 |
US |
58 | 2 |
Therapeutic response shortened, Erythema, Psoriasis, Pruritus, Thermal burn, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 442 | 26890549 |
CR |
63 | 2 |
Leukopenia, Erythema, Vitiligo, Depression, Anaemia, Nail disorder, Haematocrit decreased, Neutrophil count decreased, Lymphocyte percentage increased, Basophil percentage increased, Mean platelet volume increased, Monocyte percentage increased, Granulocytes abnormal, White blood cell count decreased, Blood bilirubin unconjugated decreased, Neutrophil percentage decreased, Bilirubin conjugated decreased, Mean cell haemoglobin increased, Blood bilirubin increased, Mean cell haemoglobin concentration increased, Pain, Hypersensitivity, Pruritus, Skin disorder, Dry skin, Alopecia, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, CALCIUM, IRBESARTAN, LORATADINE, LORATADINE ORAL, |
||||
| 443 | 26890584 |
US |
||
Erythema, Blood pressure increased, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 444 | 26890585 |
US |
||
Erythema, Blood pressure increased, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 445 | 26890901 |
CN |
54 | 2 |
Rash pruritic, Erythema, Skin swelling, Scratch, |
||||
DOLUTEGRAVIR SODIUM AND LAMIVUDINE, |
||||
| 446 | 26891018 |
EU |
67 | 2 |
Anaphylactic shock, Erythema, Product substitution issue, |
||||
CEFAZOLIN SODIUM, CEFAZOLIN, CEFAZOLIN SODIUM, CEFAZOLIN, CEFAZOLIN SODIUM, CEFAZOLIN, CEFAZOLIN SODIUM, CEFAZOLIN, PROPOFOL, PROPOFOL, PROPOFOL, PROPOFOL, ROCURONIUM BROMIDE, ROCURONIUM, ROCURONIUM BROMIDE, ROCURONIUM, ROCURONIUM BROMIDE, ROCURONIUM, ROCURONIUM BROMIDE, ROCURONIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 447 | 26891111 |
EU |
49 | 1 |
Rash, Skin swelling, Erythema, Swelling face, Skin fissures, Pain, Gait disturbance, |
||||
CARBAMAZEPINE, |
||||
| 448 | 26891311 |
US |
84 | 1 |
Presyncope, Cough, Asthenia, Blood pressure decreased, Erythema, Vomiting, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 449 | 26891456 |
AU |
72 | 1 |
Haematemesis, Agitation, Confusional state, Bronchospasm, Oxygen saturation decreased, Tachycardia, Erythema, Vomiting, Nausea, |
||||
IOHEXOL, IOHEXOL, |
||||
| 450 | 26891576 |
US |
2 | |
Peripheral swelling, Illness, Nausea, Erythema, Hypersensitivity, |
||||
RIVAROXABAN, RIVAROXABAN, |
||||
| 451 | 26891597 |
US |
71 | 1 |
Product dose omission issue, Urticaria, Dyspnoea, Vision blurred, Cough, Dizziness, Heart rate increased, Pruritus, Rash, Respiration abnormal, Erythema, Chest pain, Fatigue, Asthenia, Memory impairment, Product confusion, Off label use, Inappropriate schedule of product administration, Product storage error, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, BUPROPION HYDROCHLORIDE, FUROSEMIDE, FUROSEMIDE, CARVEDILOL, CARVEDILOL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUDESONIDE, AZELASTINE, SPIRONOLACTONE, SACUBITRIL AND VALSARTAN, ROSUVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, EMPAGLIFLOZIN, EZETIMIBE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 452 | 26891747 |
CN |
69 | 2 |
Rash, Erythema, Off label use, |
||||
SONROTOCLAX, SONROTOCLAX, SONROTOCLAX, SONROTOCLAX, |
||||
| 453 | 26891823 |
US |
2 | |
Wound infection, Erythema, Illness, Limb injury, Peripheral swelling, |
||||
BIMATOPROST, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SPIRONOLACTONE, MONTELUKAST, TIMOLOL, FOLIC ACID, ROSUVASTATIN, FUROSEMIDE, |
||||
| 454 | 26881269 |
US |
78 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
| 455 | 26881297 |
CA |
1 | |
Rectal ulcer, Erythema, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 456 | 26881330 |
US |
2 | |
Rash vesicular, Paraesthesia, Constipation, Diarrhoea, Abdominal distension, Erythema, Swelling face, Skin burning sensation, Pain, Dysphagia, Dysphonia, Dry skin, Rash erythematous, Pruritus, Hyperhidrosis, Throat tightness, Musculoskeletal stiffness, Loss of personal independence in daily activities, Feeling cold, Fatigue, Angiopathy, |
||||
DENOSUMAB, |
||||
| 457 | 26881524 |
US |
72 | 2 |
Erythema, Rash, Burning sensation, Swelling, Blister, Haemorrhage subcutaneous, Pain, Musculoskeletal stiffness, Mass, |
||||
RITUXIMAB, OMALIZUMAB, ALPRAZOLAM, SENNA LEAF, FAMOTIDINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 458 | 26881601 |
US |
||
Haematoma, Injection site erythema, Device use error, Drug ineffective, Illness, Swelling, Wrong technique in product usage process, Erythema, Product knowledge deficit, |
||||
FULVESTRANT, FULVESTRANT, |
||||
| 459 | 26881911 |
US |
10 | 2 |
Dermatitis atopic, Dry skin, Erythema, |
||||
DUPILUMAB, |
||||
| 460 | 26881933 |
US |
66 | 1 |
Hypersensitivity, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 461 | 26882219 |
US |
22 | 1 |
Dermatitis, Periorbital inflammation, Erythema, Skin exfoliation, Skin burning sensation, Pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 462 | 26882255 |
US |
2 | |
Erythema, Skin swelling, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 463 | 26882282 |
US |
1 | |
Skin burning sensation, Pruritus, Erythema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 464 | 26882373 |
US |
46 | 1 |
Feeling hot, Nausea, Erythema, Feeling drunk, Pruritus, Rash, |
||||
PEGLOTICASE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 465 | 26882503 |
US |
28 | 2 |
Headache, Eczema, Erythema, Skin irritation, Oral herpes, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 466 | 26882527 |
EU |
59 | 2 |
Limb injury, Bladder pain, Bladder disorder, Cardiovascular disorder, Sicca syndrome, Limb discomfort, Tooth disorder, Erythema, Myalgia, |
||||
ADALIMUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, AMLODIPINE, |
||||
| 467 | 26882558 |
US |
2 | |
Erythema, Pruritus, Dry skin, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, HYDROXYZINE, |
||||
| 468 | 26882660 |
US |
77 | 2 |
Urticaria, Erythema, Infusion site pruritus, Infusion site swelling, Infusion site erythema, |
||||
METHYLPREDNISOLONE SODIUM SUCCINATE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 469 | 26882708 |
US |
2 | |
Swelling face, Dyspnoea, Peripheral swelling, Rash, Heart rate increased, Maternal exposure during pregnancy, Erythema, |
||||
IRON DEXTRAN, |
||||
| 470 | 26882732 |
EU |
64 | 1 |
Dyspnoea, Chest discomfort, Erythema, Pruritus, |
||||
OXALIPLATIN, |
||||
| 471 | 26882744 |
EU |
67 | 2 |
Anaphylactic shock, Erythema, Product substitution issue, |
||||
ROCURONIUM BROMIDE, PROPOFOL, CEFAZOLIN SODIUM, CEFAZOLIN, PERINDOPRIL ERBUMINE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 472 | 26882802 |
US |
1 | |
Pain, Skin hypertrophy, Skin exfoliation, Dry skin, Wound, Pruritus, Erythema, Rash, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, |
||||
| 473 | 26882820 |
US |
47 | 1 |
Skin swelling, Pruritus, Scratch, Erythema, |
||||
DUPILUMAB, |
||||
| 474 | 26883300 |
EU |
74 | 1 |
Erythema, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 475 | 26883303 |
JP |
46 | 1 |
Chronic allograft nephropathy, Cytomegalovirus viraemia, Drug reaction with eosinophilia and systemic symptoms, Pneumonia cytomegaloviral, Staphylococcal bacteraemia, Erythema, |
||||
SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FUROSEMIDE, RITUXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, BASILIXIMAB, CEFTRIAXONE SODIUM, NIFEDIPINE, VONOPRAZAN FUMARATE, CALCIUM CARBONATE, ANTACID, SUCROFERRIC OXYHYDROXIDE, TELMISARTAN, SUVOREXANT, |
||||
| 476 | 26883316 |
EU |
42 | 2 |
Anaphylactic reaction, Rhinorrhoea, Pruritus, Erythema, Dyspnoea, Wheezing, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 477 | 26883459 |
US |
65 | |
Erythema, Drug ineffective, Product solubility abnormal, Product quality issue, Product substitution issue, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 478 | 26883752 |
US |
2 | |
Erythema, Swelling, |
||||
DUPILUMAB, |
||||
| 479 | 26884189 |
US |
35 | 2 |
Dry skin, Erythema, Injection site rash, Injection site discolouration, Injection site vesicles, Injection site reaction, Product storage error, Off label use, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 480 | 26884190 |
US |
2 | |
Tongue blistering, Skin exfoliation, Erythema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 481 | 26884413 |
EU |
74 | |
Erythema, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 482 | 26884445 |
GB |
80 | 1 |
Joint swelling, Peripheral swelling, Pustule, Noninfective gingivitis, Balanoposthitis, Erythema, |
||||
DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, RAMIPRIL, FINASTERIDE, |
||||
| 483 | 26884511 |
KR |
21 | 2 |
Eczema herpeticum, Headache, Erythema, Upper respiratory tract infection, Xerosis, Temperature intolerance, |
||||
LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 484 | 26884531 |
US |
61 | 2 |
Psoriasis, Pruritus, Pain, Thermal burn, Erythema, |
||||
BIMEKIZUMAB, |
||||
| 485 | 26884653 |
GB |
80 | 1 |
Joint swelling, Peripheral swelling, Pustule, Balanoposthitis, Erythema, Noninfective gingivitis, |
||||
DAPAGLIFLOZIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, RAMIPRIL, FINASTERIDE, |
||||
| 486 | 26884655 |
US |
1 | |
Erythema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 487 | 26885354 |
CA |
63 | 1 |
Seborrhoeic dermatitis, Eye swelling, Erythema, Skin exfoliation, |
||||
RISANKIZUMAB-RZAA, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OLANZAPINE, DUPILUMAB, |
||||
| 488 | 26885458 |
US |
||
Rash, Flushing, Erythema, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GLOFITAMAB, OXALIPLATIN, |
||||
| 489 | 26885515 |
ID |
37 | 2 |
Erythema, Breast cancer metastatic, Lymphadenopathy, |
||||
ADO-TRASTUZUMAB EMTANSINE, TRASTUZUMAB, |
||||
| 490 | 26885589 |
BR |
2 | |
Volvulus, Coma, Immunodeficiency, Immunodeficiency, Metastases to liver, Neutropenia, Metastases to pelvis, Liver injury, Bone lesion, Breast cancer, Weight decreased, Hypoaesthesia, Metastasis, Metastases to spine, Haemorrhage, Cataract, Dark circles under eyes, Wound, Carbohydrate antigen 15-3 increased, Dry skin, Nail disorder, Red blood cell count decreased, White blood cell count decreased, Drug hypersensitivity, Rash papular, Nausea, Nausea, Eye swelling, Vulvovaginal burning sensation, Illness, Alopecia, Oral discomfort, Eyelid disorder, Haematoma, Muscular weakness, Blood disorder, Skin disorder, Tumour marker decreased, Vitamin D decreased, Malaise, Blood test abnormal, Back pain, Musculoskeletal chest pain, Cardiac disorder, Pallor, Ill-defined disorder, Skin discolouration, Administration site pain, Blood creatinine abnormal, Erythema, Asthenia, Dizziness, Anxiety, Abdominal pain, Anaemia, Fatigue, Red blood cell count decreased, Pruritus, Hypotension, White blood cell count decreased, Abdominal pain upper, Somnolence, Skin discolouration, Visual impairment, Road traffic accident, Bone erosion, Labyrinthitis, Skeletal injury, Pain, Bone pain, Blood creatinine increased, Aspartate aminotransferase increased, Alanine aminotransferase increased, Somnolence, Somnolence, Somnolence, Blood urea increased, Chest pain, Platelet count decreased, Product dose omission issue, |
||||
FULVESTRANT, ZOLEDRONIC ACID, ZOLEDRONIC ACID, ZOLEDRONIC ACID, ZOLEDRONIC ACID, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, LOSARTAN, AMLODIPINE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, ANASTROZOLE, ONDANSETRON HYDROCHLORIDE, |
||||
| 491 | 26885714 |
US |
2 | |
Erythema, Erythema, Pain, Application site pain, |
||||
| 492 | 26885754 |
US |
20 | 2 |
Vomiting, Retching, Abdominal pain, Pruritus, Dermatitis, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 493 | 26885830 |
US |
||
Skin swelling, Erythema, |
||||
BUPRENORPHINE, |
||||
| 494 | 26885967 |
GB |
1 | |
Contusion, Erythema, |
||||
MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), |
||||
| 495 | 26886004 |
EU |
67 | 2 |
Anaphylactic shock, Erythema, |
||||
ROCURONIUM BROMIDE, ROCURONIUM, PROPOFOL, CEFAZOLIN SODIUM, CEFAZOLIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, PANTOPRAZOLE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 496 | 26886044 |
US |
68 | 1 |
Photosensitivity reaction, Erythema, |
||||
| 497 | 26886113 |
US |
2 | 2 |
Dermatitis atopic, Pruritus, Erythema, Therapeutic response decreased, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 498 | 26886206 |
US |
32 | 1 |
Pruritus, Erythema, Hyperhidrosis, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 499 | 26886497 |
US |
27 | 1 |
Dermatitis atopic, Erythema, Rash, |
||||
DUPILUMAB, |
||||
| 500 | 26889571 |
66 | 2 | |
Dry skin, Eyelid skin dryness, Erythema, Eyelid pain, Skin exfoliation, Therapy cessation, |
||||
LIFITEGRAST, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ADALIMUMAB-RYVK, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, FISH OIL, MAGNESIUM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
